This study assessed healthcare costs for medically attended COVID-19 (MAC) patients vs. matched controls not presenting with COVID-19, to serve as a baseline for the value of potential therapeutics.
This study assessed healthcare costs for medically attended COVID-19 (MAC) patients vs. matched controls not presenting with COVID-19, to serve as a baseline for the value of potential therapeutics.
Sign up for our newsletter to receive the latest updates.
Subscribe & receive the latest health care news right in your inbox!
© 2026 Inovalon. All rights reserved.
ABOUT INOVALON
WHO WE HELP
Need more information or have a specific question? Complete this form and we’ll be happy to show you how our cloud-based solutions can strengthen your operations.